News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,753 Results
Type
Article (40910)
Company Profile (267)
Press Release (680566)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204675)
Career Advice (2023)
Deals (35534)
Drug Delivery (110)
Drug Development (81382)
Employer Resources (173)
FDA (16411)
Job Trends (14944)
News (346394)
Policy (32729)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2567)
Accelerated approval (33)
Adcomms (24)
Allergies (142)
Alliances (49576)
ALS (169)
Alzheimer's disease (1667)
Antibody-drug conjugate (ADC) (310)
Approvals (16678)
Artificial intelligence (514)
Autoimmune disease (155)
Automation (39)
Bankruptcy (362)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (638)
Cancer (4801)
Cardiovascular disease (398)
Career advice (1708)
Career pathing (36)
CAR-T (282)
CDC (44)
Celiac Disease (2)
Cell therapy (743)
Cervical cancer (36)
Clinical research (69566)
Collaboration (1700)
Company closure (4)
Compensation (1162)
Complete response letters (56)
COVID-19 (2711)
CRISPR (89)
C-suite (845)
Cystic fibrosis (143)
Data (6226)
Decentralized trials (2)
Denatured (25)
Depression (131)
Diabetes (500)
Diagnostics (6688)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (253)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (231)
Earnings (90173)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117276)
Executive appointments (972)
FDA (19525)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1466)
Gene editing (195)
Generative AI (43)
Gene therapy (595)
GLP-1 (966)
Government (4659)
Grass and pollen (6)
Guidances (383)
Healthcare (18874)
HIV (58)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (249)
Immuno-oncology (57)
Indications (110)
Infectious disease (2981)
Inflammatory bowel disease (188)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (249)
Interviews (315)
IPO (16642)
IRA (50)
Job creations (3642)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (85)
Layoffs (546)
Leadership (31)
Legal (7951)
Liver cancer (91)
Longevity (14)
Lung cancer (648)
Lymphoma (376)
Machine learning (42)
Management (59)
Manufacturing (792)
MASH (163)
Medical device (13768)
Medtech (13821)
Mergers & acquisitions (19961)
Metabolic disorders (1266)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (315)
Neuropsychiatric disorders (88)
Neuroscience (2894)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4514)
Now hiring (67)
Obesity (594)
Opinion (259)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (226)
Parkinson's disease (280)
Partnered (33)
Patents (495)
Patient recruitment (489)
Peanut (56)
People (58872)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21683)
Phase 2 (30614)
Phase 3 (22813)
Pipeline (5281)
Policy (282)
Postmarket research (2564)
Preclinical (9197)
Press Release (64)
Prostate cancer (237)
Psychedelics (48)
Radiopharmaceuticals (279)
Rare diseases (833)
Real estate (5954)
Recruiting (70)
Regulatory (24487)
Reports (52)
Research institute (2387)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (78)
Schizophrenia (148)
Series A (238)
Series B (190)
Service/supplier (11)
Sickle cell disease (96)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3615)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (54)
Vaccines (1005)
Venture capital (88)
Weight loss (380)
Women's health (91)
Worklife (18)
Date
Today (37)
Last 7 days (560)
Last 30 days (2023)
Last 365 days (29794)
2026 (3457)
2025 (30173)
2024 (35215)
2023 (40076)
2022 (51175)
2021 (55710)
2020 (54086)
2019 (46538)
2018 (35021)
2017 (32108)
2016 (31481)
2015 (37553)
2014 (31318)
2013 (26351)
2012 (28571)
2011 (29267)
2010 (27331)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39226)
Australia (6409)
California (11287)
Canada (3287)
China (1100)
Colorado (477)
Connecticut (476)
Delaware (336)
Europe (84522)
Florida (1689)
Georgia (355)
Hawaii (3)
Idaho (61)
Illinois (859)
India (65)
Indiana (520)
Iowa (22)
Japan (430)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1381)
Massachusetts (8081)
Michigan (324)
Minnesota (628)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3000)
New Mexico (28)
New York (2973)
North Carolina (1449)
North Dakota (8)
Northern California (5516)
Ohio (333)
Oklahoma (21)
Oregon (41)
Pennsylvania (2278)
Puerto Rico (24)
Rhode Island (48)
South America (1108)
South Carolina (66)
South Dakota (1)
Southern California (4392)
Tennessee (174)
Texas (1740)
United States (39993)
Utah (334)
Vermont (1)
Virginia (260)
Washington D.C. (81)
Washington State (918)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
721,753 Results for "davita inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025
March 6, 2025
·
1 min read
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on Tuesday, May 14th, 2024 at 5:00 pm Pacific Daylight Time.
May 9, 2024
·
1 min read
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at Barclays Global Healthcare Conference 2024 on Wednesday, March 13, 2024, at 8:00 a.m. EDT.
March 8, 2024
·
1 min read
Business
DaVita Inc. 3rd Quarter 2023 Results
DaVita Inc. announced financial and operating results for the quarter ended September 30, 2023.
November 7, 2023
·
44 min read
DaVita Inc. to Participate in the TD Cowen’s Health Care Conference 2024
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at TD Cowen’s Health Care Conference 2024 on Monday, March 4, 2024, at 11:10 a.m. EST.
February 29, 2024
·
1 min read
Press Releases
DaVita Inc. 3rd Quarter 2024 Results
October 30, 2024
·
44 min read
Business
DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call
October 9, 2024
·
1 min read
BioMidwest
DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador
DaVita Inc, a leading provider of kidney care services, announced that it has agreed to terms on the expansion of its international operations in Brazil and Colombia, and its entry into Chile and Ecuador.
March 5, 2024
·
3 min read
Business
DaVita Inc. 2nd Quarter 2024 Results
August 7, 2024
·
43 min read
Business
DaVita Inc. Schedules 2nd Quarter 2023 Investor Conference Call
DaVita Inc., announced that it will hold its quarterly conference call to discuss second quarter results on Thursday, August 3rd, 2023, at 5:00 p.m. Eastern Time.
July 13, 2023
·
1 min read
1 of 72,176
Next
